Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16830968
[patent_doc_number] => 11007198
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-18
[patent_title] => ErbB/BTK inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/910208
[patent_app_country] => US
[patent_app_date] => 2020-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77757
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16910208
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/910208 | ErbB/BTK inhibitors | Jun 23, 2020 | Issued |
Array
(
[id] => 16681654
[patent_doc_number] => 10941120
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-03-09
[patent_title] => 6-aminouracil cassic acid ester with antibacterial activity and a method of preparing the same
[patent_app_type] => utility
[patent_app_number] => 16/909862
[patent_app_country] => US
[patent_app_date] => 2020-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 6
[patent_no_of_words] => 3006
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16909862
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/909862 | 6-aminouracil cassic acid ester with antibacterial activity and a method of preparing the same | Jun 22, 2020 | Issued |
Array
(
[id] => 16807747
[patent_doc_number] => 20210130300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/902935
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16902935
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/902935 | DIHYDROPYRIMIDIN-2-ONE COMPOUNDS AND MEDICAL USE THEREOF | Jun 15, 2020 | Abandoned |
Array
(
[id] => 16482529
[patent_doc_number] => 20200376129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => SUSTAINED RELEASE DELIVERY SYSTEMS COMPRISING TRACELESS LINKERS
[patent_app_type] => utility
[patent_app_number] => 16/901601
[patent_app_country] => US
[patent_app_date] => 2020-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16901601
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/901601 | SUSTAINED RELEASE DELIVERY SYSTEMS COMPRISING TRACELESS LINKERS | Jun 14, 2020 | Abandoned |
Array
(
[id] => 16328310
[patent_doc_number] => 20200299276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => 2,4-DIAMINO-PYRIMIDINE COMPOUNDS AND METHOD FOR MAKING AND USING THE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/893981
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15811
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16893981
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/893981 | 2,4-diamino-pyrimidine compounds and method for making and using the compounds | Jun 4, 2020 | Issued |
Array
(
[id] => 17937028
[patent_doc_number] => 11471460
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => Autophagy modulators for use in treating cancer
[patent_app_type] => utility
[patent_app_number] => 16/883046
[patent_app_country] => US
[patent_app_date] => 2020-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 70
[patent_no_of_words] => 18912
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16883046
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/883046 | Autophagy modulators for use in treating cancer | May 25, 2020 | Issued |
Array
(
[id] => 17776482
[patent_doc_number] => 20220242831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => IMPROVED PROCESS FOR THE PREPARATION OF ELAGOLIX AND ITS INTERMEDIATES
[patent_app_type] => utility
[patent_app_number] => 17/611804
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611804
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/611804 | IMPROVED PROCESS FOR THE PREPARATION OF ELAGOLIX AND ITS INTERMEDIATES | May 21, 2020 | Abandoned |
Array
(
[id] => 16665051
[patent_doc_number] => 10934282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => Heteroaromatic modulators of the retinoid-related orphan receptor gamma
[patent_app_type] => utility
[patent_app_number] => 16/874961
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30699
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 304
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874961
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/874961 | Heteroaromatic modulators of the retinoid-related orphan receptor gamma | May 14, 2020 | Issued |
Array
(
[id] => 16657350
[patent_doc_number] => 20210053986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => CYANO CYCLOBUTYL COMPOUNDS FOR CBL-B INHIBITION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/875917
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70816
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -69
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875917
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/875917 | Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof | May 14, 2020 | Issued |
Array
(
[id] => 16283706
[patent_doc_number] => 20200277308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => FUSED TRICYCLIC RING DERIVATIVES AS SRC HOMOLOGY-2 PHOSPHATASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/930309
[patent_app_country] => US
[patent_app_date] => 2020-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36776
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930309
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930309 | Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors | May 11, 2020 | Issued |
Array
(
[id] => 16268728
[patent_doc_number] => 20200270215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => ISOTOPOLOGUES OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE
[patent_app_type] => utility
[patent_app_number] => 16/871143
[patent_app_country] => US
[patent_app_date] => 2020-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16871143
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/871143 | Isotopologues of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide | May 10, 2020 | Issued |
Array
(
[id] => 16733815
[patent_doc_number] => 10959432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-30
[patent_title] => Microbiocidal oxadiazole derivatives
[patent_app_type] => utility
[patent_app_number] => 16/870249
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34813
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 509
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16870249
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/870249 | Microbiocidal oxadiazole derivatives | May 7, 2020 | Issued |
Array
(
[id] => 17687611
[patent_doc_number] => 20220194903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => PROCESS FOR THE PREPARATION OF FUNGICIDALLY ACTIVE STROBILURIN COMPOUNDS AND INTERMEDIATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/603430
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17603430
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/603430 | Process for the preparation of fungicidally active strobilurin compounds and intermediates thereof | Apr 16, 2020 | Issued |
Array
(
[id] => 19274382
[patent_doc_number] => 12024492
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Process for preparation of azoxystrobin and intermediates thereof
[patent_app_type] => utility
[patent_app_number] => 17/603516
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7401
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17603516
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/603516 | Process for preparation of azoxystrobin and intermediates thereof | Apr 16, 2020 | Issued |
Array
(
[id] => 18013254
[patent_doc_number] => 11505536
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Dihydroorotate dehydrogenase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/850171
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69885
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16850171
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/850171 | Dihydroorotate dehydrogenase inhibitors | Apr 15, 2020 | Issued |
Array
(
[id] => 16206512
[patent_doc_number] => 20200239502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/847477
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16847477
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/847477 | Dioxolane analogues of uridine for the treatment of cancer | Apr 12, 2020 | Issued |
Array
(
[id] => 16343540
[patent_doc_number] => 20200308190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/844262
[patent_app_country] => US
[patent_app_date] => 2020-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50728
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16844262
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/844262 | HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS | Apr 8, 2020 | Abandoned |
Array
(
[id] => 18492231
[patent_doc_number] => 11697641
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-11
[patent_title] => Impact of trace elements in the Grignard reaction
[patent_app_type] => utility
[patent_app_number] => 17/442862
[patent_app_country] => US
[patent_app_date] => 2020-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3172
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17442862
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/442862 | Impact of trace elements in the Grignard reaction | Mar 24, 2020 | Issued |
Array
(
[id] => 19411707
[patent_doc_number] => 12077512
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-03
[patent_title] => Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment
[patent_app_type] => utility
[patent_app_number] => 17/442474
[patent_app_country] => US
[patent_app_date] => 2020-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18083
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17442474
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/442474 | Compositions and methods for reducing tactile dysfunction, anxiety, and social impairment | Mar 24, 2020 | Issued |
Array
(
[id] => 16297732
[patent_doc_number] => 20200283455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/826623
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16826623
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/826623 | SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF | Mar 22, 2020 | Abandoned |